174 related articles for article (PubMed ID: 7812773)
21. Increased binding of 3H-L-deprenyl in spinal cords from patients with amyotrophic lateral sclerosis as demonstrated by autoradiography.
Aquilonius SM; Jossan SS; Ekblom JG; Askmark H; Gillberg PG
J Neural Transm Gen Sect; 1992; 89(1-2):111-22. PubMed ID: 1418862
[TBL] [Abstract][Full Text] [Related]
22. Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease.
Olney NT; Bischof A; Rosen H; Caverzasi E; Stern WA; Lomen-Hoerth C; Miller BL; Henry RG; Papinutto N
PLoS One; 2018; 13(11):e0208255. PubMed ID: 30496320
[TBL] [Abstract][Full Text] [Related]
23. Distribution of the N-methyl-D-aspartate glutamate receptor subunit NR2A in control and amyotrophic lateral sclerosis spinal cord.
Samarasinghe S; Virgo L; de Belleroche J
Brain Res; 1996 Jul; 727(1-2):233-7. PubMed ID: 8842405
[TBL] [Abstract][Full Text] [Related]
24. N-methyl-D-aspartate receptors are transiently expressed in the developing spinal cord ventral horn.
Kalb RG; Lidow MS; Halsted MJ; Hockfield S
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8502-6. PubMed ID: 1356265
[TBL] [Abstract][Full Text] [Related]
25. Decreased synaptophysin immunoreactivity of the anterior horns in motor neuron disease.
Sasaki S; Maruyama S
Acta Neuropathol; 1994; 87(2):125-8. PubMed ID: 8171961
[TBL] [Abstract][Full Text] [Related]
26. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons.
Mu X; He J; Anderson DW; Trojanowski JQ; Springer JE
Ann Neurol; 1996 Sep; 40(3):379-86. PubMed ID: 8797527
[TBL] [Abstract][Full Text] [Related]
27. The expression of the glutamate re-uptake transporter excitatory amino acid transporter 1 (EAAT1) in the normal human CNS and in motor neurone disease: an immunohistochemical study.
Banner SJ; Fray AE; Ince PG; Steward M; Cookson MR; Shaw PJ
Neuroscience; 2002; 109(1):27-44. PubMed ID: 11784698
[TBL] [Abstract][Full Text] [Related]
28. [3H]phorbol 12,13-dibutyrate/PKC binding in thoracic spinal cord: no change in amyotrophic lateral sclerosis.
Krieger C; Jacques D; Parent A; Quirion R
Neuroreport; 1995 Jul; 6(10):1381-4. PubMed ID: 7488729
[TBL] [Abstract][Full Text] [Related]
29. Selective retrograde transport of D-aspartate in spinal interneurons and cortical neurons of rats.
Rustioni A; Cuenod M
Brain Res; 1982 Mar; 236(1):143-55. PubMed ID: 6175376
[TBL] [Abstract][Full Text] [Related]
30. Alteration in amino acids in motor neurons of the spinal cord in amyotrophic lateral sclerosis.
Ono S; Imai T; Takahashi K; Jinnai K; Kanda F; Fukuoka Y; Hashimoto K; Shimizu N; Nagao K
J Neurol Sci; 1999 Aug; 167(2):121-6. PubMed ID: 10521551
[TBL] [Abstract][Full Text] [Related]
31. TDP-43 in differential diagnosis of motor neuron disorders.
Dickson DW; Josephs KA; Amador-Ortiz C
Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
[TBL] [Abstract][Full Text] [Related]
32. Substance P receptors in the human spinal cord: decrease in amyotrophic lateral sclerosis.
Dietl MM; Sanchez M; Probst A; Palacios JM
Brain Res; 1989 Mar; 483(1):39-49. PubMed ID: 2539890
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis.
Adem A; Ekblom J; Gillberg PG; Jossan SS; Höög A; Winblad B; Aquilonius SM; Wang LH; Sara V
J Neural Transm Gen Sect; 1994; 97(1):73-84. PubMed ID: 7888151
[TBL] [Abstract][Full Text] [Related]
34. Forme fruste or incipient form of widespread-type amyotrophic lateral sclerosis, or motor neuron disease with pallido-nigro-luysian atrophy? An autopsy case report.
Hashimoto T; Matsubara S; Mochizuki Y; Tsuji S; Mizutani T; Oyanagi K
Neuropathology; 2008 Jun; 28(3):309-16. PubMed ID: 18179405
[TBL] [Abstract][Full Text] [Related]
35. Ultrastructural evidence of neurofilament involvement in immune-mediated motor neuron injury.
Liu YL; Guo YS; Xu L; Wu SY; Wu DX; Yang C; Li CY
Neurol Res; 2008 Nov; 30(9):990-4. PubMed ID: 18662498
[TBL] [Abstract][Full Text] [Related]
36. Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mutant mouse.
Fujita K; Yamauchi M; Matsui T; Titani K; Takahashi H; Kato T; Isomura G; Ando M; Nagata Y
Brain Res; 1998 Feb; 785(1):31-40. PubMed ID: 9526038
[TBL] [Abstract][Full Text] [Related]
37. Quantitative autoradiographic analysis of excitatory amino acid receptors in the cat spinal cord.
Mitchell JJ; Anderson KJ
Neurosci Lett; 1991 Apr; 124(2):269-72. PubMed ID: 1648695
[TBL] [Abstract][Full Text] [Related]
38. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease.
Ince P; Stout N; Shaw P; Slade J; Hunziker W; Heizmann CW; Baimbridge KG
Neuropathol Appl Neurobiol; 1993 Aug; 19(4):291-9. PubMed ID: 8232749
[TBL] [Abstract][Full Text] [Related]
39. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
Mitsumoto H; Ulug AM; Pullman SL; Gooch CL; Chan S; Tang MX; Mao X; Hays AP; Floyd AG; Battista V; Montes J; Hayes S; Dashnaw S; Kaufmann P; Gordon PH; Hirsch J; Levin B; Rowland LP; Shungu DC
Neurology; 2007 Apr; 68(17):1402-10. PubMed ID: 17452585
[TBL] [Abstract][Full Text] [Related]
40. High 3H-vesamicol binding in ALS motor neurons--autoradiographic visulalization of hyperactivities?
Grundström E; Gillberg PG; Aquilonius SM
Acta Neurol Scand; 2001 Jan; 103(1):2-6. PubMed ID: 11153883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
